187 related articles for article (PubMed ID: 22290316)
1. Manganese and ammonia interactions in the brain of cirrhotic rats: effects on brain ammonia metabolism.
Rivera-Mancía S; Ríos C; Montes S
Neurochem Res; 2012 May; 37(5):1074-84. PubMed ID: 22290316
[TBL] [Abstract][Full Text] [Related]
2. Bumetanide increases manganese accumulation in the brain of rats with liver damage.
Montes S; Castro-Chávez A; Florian-Soto C; Heras-Romero Y; Ríos C; Rivera-Mancía S
Eur J Pharmacol; 2016 Mar; 774():127-34. PubMed ID: 26851372
[TBL] [Abstract][Full Text] [Related]
3. Role of manganese accumulation in increased brain glutamine of the cirrhotic rat.
Montes S; Alcaraz-Zubeldia M; Muriel P; Rios C
Neurochem Res; 2003 Jun; 28(6):911-7. PubMed ID: 12718445
[TBL] [Abstract][Full Text] [Related]
4. A method to induce manganese accumulation in the brain of the cirrhotic rat and its evaluation.
Montes S; Alcaraz-Zubeldia M; Ríos C; Muriel P
Brain Res Brain Res Protoc; 2002 Feb; 9(1):9-15. PubMed ID: 11852265
[TBL] [Abstract][Full Text] [Related]
5. Morphological changes of rat astrocytes induced by liver damage but not by manganese chloride exposure.
Rivera-Mancía S; Montes S; Méndez-Armenta M; Muriel P; Ríos C
Metab Brain Dis; 2009 Jun; 24(2):243-55. PubMed ID: 19353255
[TBL] [Abstract][Full Text] [Related]
6. L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats.
Davies NA; Wright G; Ytrebø LM; Stadlbauer V; Fuskevåg OM; Zwingmann C; Davies DC; Habtesion A; Hodges SJ; Jalan R
Hepatology; 2009 Jul; 50(1):155-64. PubMed ID: 19437490
[TBL] [Abstract][Full Text] [Related]
7. Metabolic changes of the reduction of manganese intake in the hepatic encephalopathy rat: NMR- and MS-based metabolomics study.
Lu J; Li Y; Zhang C; Yang X; Qiang J
Biometals; 2022 Oct; 35(5):935-953. PubMed ID: 35857253
[TBL] [Abstract][Full Text] [Related]
8. The interaction of ammonia and manganese in abnormal metabolism of minimal hepatic encephalopathy: A comparison metabolomics study.
Liu XF; Lu JJ; Li Y; Yang XY; Qiang JW
PLoS One; 2023; 18(8):e0289688. PubMed ID: 37540683
[TBL] [Abstract][Full Text] [Related]
9. Reduction of manganese intake improves neuropsychological manifestations in rats with minimal hepatic encephalopathy.
Li Y; Mei LH; Qiang JW; Ji CX; Ju S
Neuroscience; 2017 Apr; 347():148-155. PubMed ID: 28193543
[TBL] [Abstract][Full Text] [Related]
10. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.
Rose C; Butterworth RF; Zayed J; Normandin L; Todd K; Michalak A; Spahr L; Huet PM; Pomier-Layrargues G
Gastroenterology; 1999 Sep; 117(3):640-4. PubMed ID: 10464140
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibition of brain phosphate-activated glutaminase by ammonia and manganese.
Rivera-Mancía S; Tristán-López L; Hernández-Díaz K; Rivera-Espinosa L; Ríos C; Montes S
J Trace Elem Med Biol; 2020 Dec; 62():126625. PubMed ID: 32717575
[TBL] [Abstract][Full Text] [Related]
12. Effect of phosphatidylserine on cirrhosis-induced hepatic encephalopathy: Response to acute endotoxemia in cirrhotic rats.
Zamanian G; Partoazar A; Tavangar SM; Rashidian A; Mirzaei P; Niaz Q; Sharifi K; Dehpour AR; Jazaeri F
Life Sci; 2020 Jul; 253():117606. PubMed ID: 32320707
[TBL] [Abstract][Full Text] [Related]
13. Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy.
Weissenborn K; Ahl B; Fischer-Wasels D; van den Hoff J; Hecker H; Burchert W; Köstler H
Gut; 2007 Dec; 56(12):1736-42. PubMed ID: 17660226
[TBL] [Abstract][Full Text] [Related]
14. AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile duct-ligated rats.
Bosoi CR; Parent-Robitaille C; Anderson K; Tremblay M; Rose CF
Hepatology; 2011 Jun; 53(6):1995-2002. PubMed ID: 21384402
[TBL] [Abstract][Full Text] [Related]
15. Striatal manganese accumulation induces changes in dopamine metabolism in the cirrhotic rat.
Montes S; Alcaraz-Zubeldia M; Muriel P; Ríos C
Brain Res; 2001 Feb; 891(1-2):123-9. PubMed ID: 11164815
[TBL] [Abstract][Full Text] [Related]
16. Reduction in hyperammonaemia by ornithine phenylacetate prevents lipopolysaccharide-induced brain edema and coma in cirrhotic rats.
Wright G; Vairappan B; Stadlbauer V; Mookerjee RP; Davies NA; Jalan R
Liver Int; 2012 Mar; 32(3):410-9. PubMed ID: 22151131
[TBL] [Abstract][Full Text] [Related]
17. Effect of sirolimus on liver cirrhosis and hepatic encephalopathy of common bile duct-ligated rats.
Wu KC; Huang HC; Chang T; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Lee FY; Chang CC; Lee SD
Eur J Pharmacol; 2018 Apr; 824():133-139. PubMed ID: 29444470
[TBL] [Abstract][Full Text] [Related]
18. Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia.
Bak LK; Iversen P; Sørensen M; Keiding S; Vilstrup H; Ott P; Waagepetersen HS; Schousboe A
Metab Brain Dis; 2009 Mar; 24(1):135-45. PubMed ID: 19067142
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology.
Butterworth RF
Drugs; 2019 Feb; 79(Suppl 1):17-21. PubMed ID: 30706423
[TBL] [Abstract][Full Text] [Related]
20. Partial pressure of NH₃ in cirrhotic patients with and without hepatic encephalopathy.
He Y; Li G; Song H; Luo T; Gao B; Xu J
J Gastrointestin Liver Dis; 2011 Jun; 20(2):169-74. PubMed ID: 21725514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
